Study Suggests Zinc Remedy Prevents Colds

Statistical results of a retrospective analysis suggest that COLD-EEZE®, an over-the-counter zinc cold remedy from The Quigley Corp. is also an effective means of prevention. A company news release stated that when taken daily, COLD-EEZE® (a 13.3-mg zinc gluconate glycine lozenge) statistically decreased the number of colds experienced per year, reducing the median from 1.5 to zero.

The study also found that the use of COLD-EEZE® to treat the common cold statistically reduced the use of antibiotics for respiratory illnesses from 39.3% to 3% when COLD-EEZE® was administered as a first-line treatment approach.

Additionally, the study reinforced the findings of previous clinical trials that concluded that COLD-EEZE® reduced the median duration of a cold by 4 days, the company stated.

The findings were the result of analyzing 3 years' worth of clinical data at the Heritage School in Provo, Utah. The study comprised more than 170,000 patient days in a student population of 317 adolescents ranging from 11 years to 17 years.